These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34867177)

  • 1. Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies.
    Jiang J; Liu Y; Wu Q
    Front Neurosci; 2021; 15():781722. PubMed ID: 34867177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
    Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?
    Marwarha G; Ghribi O
    Exp Gerontol; 2015 Aug; 68():13-8. PubMed ID: 25261765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    Tsigelny IF; Crews L; Desplats P; Shaked GM; Sharikov Y; Mizuno H; Spencer B; Rockenstein E; Trejo M; Platoshyn O; Yuan JX; Masliah E
    PLoS One; 2008 Sep; 3(9):e3135. PubMed ID: 18769546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
    Kumar D; Kumar P
    Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
    Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
    Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Nanotechnology for Treatment of Alzheimer's and Parkinson's Disease.
    Li A; Tyson J; Patel S; Patel M; Katakam S; Mao X; He W
    Front Bioeng Biotechnol; 2021; 9():672594. PubMed ID: 34113606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein aggregation and neurodegenerative diseases.
    Ma QL; Chan P; Yoshii M; Uéda K
    J Alzheimers Dis; 2003 Apr; 5(2):139-48. PubMed ID: 12719631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
    Duyckaerts C; Clavaguera F; Potier MC
    Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.